News roundup Friday, April 26

The latest articles from BioStock
» CombiGene's CEO on the bid for the industry colleague
» Saniona's two pillars
» Strong first quarter for Iconovo
» Enorama creates new revenue engine
» Eli Lilly receives $375 million for off-patent antibiotic 
» Karolinska Development's Dilafor investment increases value by SEK 17 million

Read BioStock's latest newsletter for week 16 here
The Stem Cell Company Nextcell Pharma has contacted Idogen regarding an indicative interest in a merger. Such a merger would be implemented by NextCell Pharma making a public tender offer for Idogen's shares and offering its own shares as consideration. More information will be announced next week. Read more.
BioInvent receives milestone payment of EUR 0,75 million within the framework of the collaboration with Mitsubishi Tanabe Pharma. Read more.
C-ROW and OPASCAL announces a collaboration agreement to improve the safety and accuracy of radiotherapy departments with a solution that combines the two companies' products. Under the agreement, OPASCA will manufacture its patient validation solution for C-RAD, which will sell it in selected markets under the name cPatient. Read more.
Novo Nordisk applies for market approval in EU - for oral semaglutide, a treatment for type 2 diabetes. Read more.
The board of directors Xintela announces that Peter Edman is proposed as a new board member for the Annual General Meeting on May 27. Read more.
A new analysis of Iconovo has been published by Erik Penser Bank. Read more.
Sanionas The nomination committee has proposed Edward C. Saltzman to a new board member. Read more.
Matthias Bengtsson It is proposed that the Annual General Meeting elects a new board member in Nanologicas board of directors. Current board member Peter von Ehrenheim has declined re-election. Read more.
Smell presents the nomination committee's proposal for the 2019 Annual General Meeting. Read more.
Q-line will publish the company's interim report for the period January - March this year on Friday, May 3. Read more.
Although Medicover The interim report for January-March 2019 will be published on May 3. Read more.
The board of directors PolarCool has decided that the record date for the reverse stock split will be Wednesday, May 8. Read more.
Penser Access publishes an analysis of Spago Nanomedical. Read more.
Reports/Communiqués:
Active Biotech  AcuCort  ADDvise  Arcoma  AstraZeneca  BioInvent  Clinical Laserthermia Systems  Dicot  European Institute of Science  Gabather  IRLAB  Karessa Pharma  Karo Pharma  Klaria  SUFFER  Lumito  NeuroVive  PolarCool  Pharmacologist  S2Medical  Sedana Medical  ViroGates  Vistin Pharma  XVIVO Perfusion
Invitations to general meetings:
Autopsy  Respirator  Saniona  Xintela

News received yesterday:
Clinical Laserthermia Systems will participate in this year's edition of Anglo-Nordic Life Science Conference in London on May 8-9 when CEO Lars-Erik Eriksson is on site to present the company. Read more.
RhoVac announced that Anders Mansson will take up his position as Vice President and Business Development Manager in May. Read more.
Gabathers Phase I clinical study in healthy volunteers with single and increasing doses (SAD study) of GT-002, has been successfully completed and no drug-related adverse events have been reported. Read more.
Redsense Medical has received notice of approval of a technology patent in Canada. The patent will be valid until March 22, 2033. Read more.
CBC Investment Group has invested in Colzyx which is developing a completely new type of product in the wound care market. The investment will be used for continued product development by the Wound Association WOUNDCOM. Read more.
ExpreS2ion Biotech announced the publication of a scientific article in Cellular Microbiology, which provides a first proof of concept in an animal model for a next-generation malaria vaccine that targets a newly discovered molecular “key” that the deadly malaria parasite uses to enter human blood cells. Read more.
ViroGates has signed an agreement with the Danish Amager Hospital current suPARnostic. Read more.
RaySearch Laboratories exhibiting at the congress ESTRO 38 in Milan, Italy, between April 27 and 29. Read more.
Attana will participate in Small Business Day June 3 in Stockholm. Read more.
Tuesday, May 14th at 12.00:XNUMX noon MediaRights a lunch presentation for shareholders and other interested parties at Erik Penser Bank. Read more.
Arjo will publish its interim report for January-March 2019 on Tuesday, May 7. Read more.
Winners in the lunch trade: Enorama +16,18%, AlphaHelix +10,79%, A1M Pharma +9,66%, Redsense Medical +4,23%, Bioservo Technologies +3,95%, ADDvise +3,87%